Cash equivalent EPS 2.87 vs ARCe/Cons 2.34/2.29. Cash equiv. ROE 17.9%Beat driven by insurance, financial results and lower effective tax rateSolvency margin 200%, in line with estimatesSecond buyback tranche of NOK 750m initiated as expected
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Cash equivalent EPS 2.87 vs ARCe/Cons 2.34/2.29. Cash equiv. ROE 17.9%Beat driven by insurance, financial results and lower effective tax rateSolvency margin 200%, in line with estimatesSecond buyback tranche of NOK 750m initiated as expected
